BETTER BIOPHARMA

47:52 Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.
Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

In this episode of "Better Biopharma," host Tyler Menichiello is joined by Bonum Therapeutics' chief scientific officer, Diane Hollenbaugh, Ph.D., and chief business officer, Neela Patel, Ph.D. 

ABOUT BETTER BIOPHARMA

“How can biopharma improve?” This question is the guiding ethos of the Better Biopharma podcast. Through conversations with experts across the biopharma landscape, host Tyler Menichiello explores the work being done to make better medicines and optimize manufacturing. Each episode is a dive into the guest's methods, their curiosity, and their determination. By shining a light on the visionaries pushing the industry forward, Better Biopharma aims to inform and inspire their peers to continue doing the same.

Apple Spotify   YouTube

MEET YOUR HOST

Tyler Menichiello is Chief Editor at Bioprocess Online. He aims to investigate the industry’s most prevalent challenges and emerging best practices to provide both interesting and actionable content for industry leaders.

LINKEDIN

Interested in joining us on air? Contact us

LATEST EPISODES

47:52 Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

44:31 Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

36:41 Engineering Bacterial Vector-Based Immunotherapies With OS Therapies’ Paul Romness and Robert Petit, Ph.D.

Engineering Bacterial Vector-Based Immunotherapies With OS Therapies' Paul Romness and Robert Petit, Ph.D.

32:53 How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

1:00:43 CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.

CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.

36:14 Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

48:42 Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

43:48 Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

44:34 25_07_BetBio_Lumen_1280x720_Splash

Using Algae To Manufacture Oral Biologics With Lumen Bioscience's Craig Behnke, Ph.D.

2:48 25_07_BetBio_PilotEpisode_1280x720_Splash

PILOT: Introducing Better Biopharma

Better Biopharma Podcast Page

DISCOVERY

47:52 Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

44:31 Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

32:53 How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

36:14 Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

48:42 Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

43:48 Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

REGULATORY

44:31 Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

36:41 Engineering Bacterial Vector-Based Immunotherapies With OS Therapies’ Paul Romness and Robert Petit, Ph.D.

Engineering Bacterial Vector-Based Immunotherapies With OS Therapies' Paul Romness and Robert Petit, Ph.D.

36:14 Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

48:42 Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

UPSTREAM CELL LINE DEVELOPMENT

1:00:43 CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.

CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.

43:48 Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

44:34 25_07_BetBio_Lumen_1280x720_Splash

Using Algae To Manufacture Oral Biologics With Lumen Bioscience's Craig Behnke, Ph.D.